A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

How industry and the NHS can work together to bridge the diagnostic gap in COPD Lord Darzi’s recent report on the state of ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...

A precise and realistic TPP can define a clear path to market and commercial success by bridging the gap between research and ...

Eran Harary, Senior Vice President of Global Early Clinical Development at Teva, said: “This collaboration will provide ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

Our luminaries look across the pharmaverse with conclusions and curiosity ...

Cytomos has announced that it has raised $5m in an oversubscribed funding round to scale up production of its cell analysis ...

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles ...

Commit Biologics has announced the appointment of Mikkel Wandahl Pedersen as Chief Scientific Officer (CSO). Mikkel is a ...

Imagine cruising down a highway, with the hum of the engine and road beneath you, travelling towards your destination. On the ...